News

Skin-lightening products may not be safe, FDA warns


 

References

Use of an injectable skin-lightening product poses a potential health risk to consumers, as no such product has been approved, according to a consumer alert from the Food and Drug Administration.

Injectable skin products – sold online or in some retail locations such as health spas – can contain a wide range of ingredients, such as glutathione, vitamin C, collagen, or human placenta. They are advertised as being able to lighten skin, correct uneven skin tone, and clear blemishes. More exaggerated claims include the ability to treat Parkinson’s disease and liver disorders.

Although makers and distributors of unlicensed skin-lightening products have been subject to legal action and recalls in the past, the products continue to be marketed. Also of concern are noninjectable, over-the-counter skin-bleaching products that contain ammoniated mercury.

“In general, consumers should be cautious of any product marketed online with exaggerated claims on safety and effectiveness. They also should consult their health care practitioner before deciding to use any new product,” In Kim, an FDA pharmacist, said in a written statement.

Find the full statement on the FDA website here.

lfranki@frontlinemedcom.com

Recommended Reading

What Is Your Diagnosis? Verrucous Carcinoma
MDedge Dermatology
Update on Hyaluronic Acid Fillers for Facial Rejuvenation
MDedge Dermatology
Evaluating Endoleaks in the Dermatology Office
MDedge Dermatology
How to Teach the Potassium Hydroxide Preparation: A Disappearing Clinical Art Form
MDedge Dermatology
Indoor Tanning Is More Harmful Than Americans Believe
MDedge Dermatology
Survey identifies top cosmetic concerns
MDedge Dermatology
Treatment options for lentigo maligna far from perfect
MDedge Dermatology
Early intervention may forestall menopause-related skin aging
MDedge Dermatology
Melanoma regression a positive prognostic indicator
MDedge Dermatology
Characterization of Knuckle (Garrod) Pads Using Optical Coherence Tomography In Vivo
MDedge Dermatology